|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
28 April 2015 |
|
Main ID: |
NCT02239458 |
|
Date of registration:
|
08/09/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
June 2015 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT02239458 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Ram Weiss, MD PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
ramw@ekmd.huji.ac.il |
|
Affiliation:
|
|
|
|
Name:
|
Ram Weiss, MD PhD |
|
Address:
|
|
|
Telephone:
|
+972-50-894-6469 |
|
Email:
|
ramw@ekmd.huji.ac.il |
|
Affiliation:
|
|
|
|
Name:
|
Eitan Kerem, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hadassah Ein Kerem |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age greater than 18 years
- Diagnosis of CF
- No CFRD on baseline OGTT
- Normal kidney function
- No history of pancreatitis
- Able and willing to consent and participate
Exclusion Criteria:
- Acute illness/exacerbation of CF associated lung disease
- Receiving immune-modulators following lung/pancreas transplant
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cystic Fibrosis
|
|
Intervention(s)
|
|
Drug: Saxagliptin
|
|
Primary Outcome(s)
|
|
Oral Disposition Index
[Time Frame: The ODI will be calculated at baseline (Day 1) and at End point (day 90- 3 months)]
|
|
Secondary ID(s)
|
|
0388-14-HMO
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|